These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15326145)

  • 1. Ocular bioerodible minitablets as strategy for the management of microbial keratitis.
    Weyenberg W; Vermeire A; Dhondt MM; Adriaens E; Kestelyn P; Remon JP; Ludwig A
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3229-33. PubMed ID: 15326145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative tear concentrations of topically applied ciprofloxacin, ofloxacin, and norfloxacin in human eyes.
    Akkan AG; Mutlu I; Ozyazgan S; Gök A; Yigit U; Ozüner Z; Senses V; Pekel H
    Int J Clin Pharmacol Ther; 1997 May; 35(5):214-7. PubMed ID: 9174877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tear concentrations of topically applied ciprofloxacin.
    Limberg M; Buggé C
    Cornea; 1994 Nov; 13(6):496-9. PubMed ID: 7842707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of different sterilisation methods on the properties of bioadhesive powders and ocular minitablets, and clinical evaluation.
    Weyenberg W; Vermeire A; D'Haese E; Vanhaelewyn G; Kestelyn P; Callens F; Nelis HJ; Remon JP; Ludwig A
    Eur J Pharm Sci; 2004 Sep; 23(1):77-87. PubMed ID: 15324925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of topically applied ciprofloxacin in equine tears.
    Hendrix DV; Stuffle JL; Cox SK
    Vet Ophthalmol; 2007; 10(6):344-7. PubMed ID: 17970994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of topically applied ciprofloxacin in rabbit tears.
    Green LC; Callegan MC; Engel LS; Shimomura Y; Jasheway DW; O'Callaghan RJ; Hill JM
    Jpn J Ophthalmol; 1996; 40(1):123-6. PubMed ID: 8739510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of topically applied ciprofloxacin in tears of mesocephalic and brachycephalic dogs.
    Hendrix DV; Cox SK
    Vet Ophthalmol; 2008; 11(1):7-10. PubMed ID: 18190345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciprofloxacin and ofloxacin aqueous humor concentrations after topical administration in dogs undergoing cataract surgery.
    Yu-Speight AW; Kern TJ; Erb HN
    Vet Ophthalmol; 2005; 8(3):181-7. PubMed ID: 15910371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a prolonged-release gastroretentive tablet formulation of ciprofloxacin hydrochloride: pharmacokinetic characterization in healthy human volunteers.
    Mostafavi A; Emami J; Varshosaz J; Davies NM; Rezazadeh M
    Int J Pharm; 2011 May; 409(1-2):128-36. PubMed ID: 21371548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjunctival tissue pharmacokinetic properties of topical azithromycin 1% and moxifloxacin 0.5% ophthalmic solutions: a single-dose, randomized, open-label, active-controlled trial in healthy adult volunteers.
    Torkildsen G; O'Brien TP
    Clin Ther; 2008 Nov; 30(11):2005-14. PubMed ID: 19108788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and characterization of sponge-like acyclovir ocular minitablets.
    Refai H; Tag R
    Drug Deliv; 2011 Jan; 18(1):38-45. PubMed ID: 20804440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of bioequivalence of ciprofloxacin in healthy male subjects using HPLC.
    Khan MK; Khan MF
    Pak J Pharm Sci; 2008 Jul; 21(3):299-306. PubMed ID: 18614429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of topical dexamethasone and ciprofloxacin on bacterial flora of healthy conjunctiva.
    Ermis SS; Aktepe OC; Inan UU; Ozturk F; Altindis M
    Eye (Lond); 2004 Mar; 18(3):249-52. PubMed ID: 15004572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of a novel extended-release ciprofloxacin in healthy volunteers.
    Washington CB; Hou SY; Campanella C; Hughes N; Brown S; Berner B
    J Clin Pharmacol; 2005 Nov; 45(11):1236-44. PubMed ID: 16239356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioequivalence evaluation of two different formulations of ciprofloxacin tablets in healthy volunteers.
    Hassan Y; Alfadly SO; Azmin MN; Peh KK; Tan TF; Noorizan AA; Ismail O
    Singapore Med J; 2007 Sep; 48(9):819-23. PubMed ID: 17728962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciprofloxacin prolonged-release tablets do not affect warfarin pharmacokinetics and pharmacodynamics.
    Washington C; Hou SY; Hughes NC; Campanella C; Berner B
    J Clin Pharmacol; 2007 Oct; 47(10):1320-6. PubMed ID: 17724088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetration of topical 0.3% ciprofloxacin into human aqueous humor.
    Kalayci D; Basci N; Akpek E; Hasiripi H; Bozkurt A
    Ophthalmic Surg Lasers; 1996 Jan; 27(1):21-4. PubMed ID: 8630751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of topical lomefloxacin 0.3 per cent versus topical ciprofloxacin 0.3 per cent for the treatment of presumed bacterial corneal ulcers.
    Booranapong W; Kosrirukvongs P; Prabhasawat P; Srivannaboon S; Suttiprakarn P
    J Med Assoc Thai; 2004 Mar; 87(3):246-54. PubMed ID: 15117040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged delivery of ciprofloxacin hydrochloride from hydrophilic ocular inserts.
    Samanta A; Ghosal SK
    Acta Pol Pharm; 2004; 61(5):343-9. PubMed ID: 15747690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial activity of the white precipitate formed on the corneal surface after treatment with ciprofloxacin ophthalmic solution.
    Madhavan HN; Rao SK; Joseph PR; Sulochana KN
    Cornea; 1999 Sep; 18(5):549-52. PubMed ID: 10487428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.